Company intelligence / Profile preview

CaveoMed

Tübingen, Baden-Württemberg, Germanycaveomed.com ↗

Ownership: Private
Development stage: Commercial

Overview

CaveoMed has developed the CaveoVasc® system, a novel vascular protection device designed to reduce bleeding complications during catheter-directed thrombolysis. First-in-man studies have shown reduced rates of bleeding at the puncture site and improved procedural success without pain or treatment failure.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Drug pipeline

3 assets

CaveoVasc

Commercial

Indications: Vascular protection, Bleeding prevention

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on CaveoMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CaveoMed.

Explore the full profile